Skip to main content

Stonepine Capital Management, LLC

Position in ABEO — Abeona Therapeutics Inc.

CIK 1440771 BEND, OR

Position in ABEO

as of Mar 31, 2026 · filed May 14, 2026
Position Value
$3,344,709
-$394,382 QoQ
Shares Held
746,587
+5.2% QoQ
Ownership
1.31%
of shares outstanding
% of Portfolio
3.01%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2025
4 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ABEO Over Time

Shares Held

Position Value (USD)

Derivatives in ABEO

reported options exposure · as of Mar 31, 2026
CallValue
$448,000
CallShares
100,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Stonepine Capital Management, LLC holds $96,227,473 across 56 Biotechnology names. ABEO ranks #8 (3.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
8 ABEO
Abeona Therapeutics Inc.
This page
746,587 $3,344,709

All Filings in ABEO

Export CSV
6 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $3,344,709 746,587
2026-03-31 $448,000 100,000
2025-12-31 $1,054,000 200,000
2025-12-31 $3,739,091 709,505
2025-09-30 $2,381,121 450,970
2025-06-30 $255,600 45,000